cellvie, a company based in Houston, Texas, is developing a mitochondrial transplantation therapy to help reduce the damage caused by ischemia-reperfusion injury. The treatment involves delivering isolated mitochondria to cells that are affected by ischemia to help mitigate the dysfunctional metabolism that contributes to cell death in that co (Read more...)